Delphi Management Inc buys $2.6 Million stake in Laboratory Corp. of America Holdings (LH)

Laboratory Corp. of America Holdings (LH) : Delphi Management Inc scooped up 864 additional shares in Laboratory Corp. of America Holdings during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 13, 2016. The investment management firm now holds a total of 20,375 shares of Laboratory Corp. of America Holdings which is valued at $2.6 Million.Laboratory Corp. of America Holdings makes up approximately 1.61% of Delphi Management Inc’s portfolio.

Other Hedge Funds, Including , Davidson Investment Advisors boosted its stake in LH in the latest quarter, The investment management firm added 1,693 additional shares and now holds a total of 50,574 shares of Laboratory Corp. of America Holdings which is valued at $6.4 Million. Laboratory Corp. of America Holdings makes up approx 1.09% of Davidson Investment Advisors’s portfolio. Mosaic Family Wealth sold out all of its stake in LH during the most recent quarter. The investment firm sold 35 shares of LH which is valued $4,439.Zacks Investment Management boosted its stake in LH in the latest quarter, The investment management firm added 25,695 additional shares and now holds a total of 142,487 shares of Laboratory Corp. of America Holdings which is valued at $18.1 Million. Laboratory Corp. of America Holdings makes up approx 0.57% of Zacks Investment Management’s portfolio. Brown Advisory Securities sold out all of its stake in LH during the most recent quarter. The investment firm sold 1,774 shares of LH which is valued $224,979.Whittier Trust Co boosted its stake in LH in the latest quarter, The investment management firm added 300 additional shares and now holds a total of 438 shares of Laboratory Corp. of America Holdings which is valued at $54,890.

Laboratory Corp. of America Holdings closed down -0.58 points or -0.45% at $127.58 with 11,34,385 shares getting traded on Wednesday. Post opening the session at $128.38, the shares hit an intraday low of $127.26 and an intraday high of $129.29 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.

On the company’s financial health, Laboratory Corp. of America Holdings reported $2.02 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Apr 25, 2016. Analyst had a consensus of $1.96. The company had revenue of $2295.20 million for the quarter, compared to analysts expectations of $2184.25 million. The company’s revenue was up 29.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.73 EPS.

Many Wall Street Analysts have commented on Laboratory Corp. of America Holdings. Company shares were Reiterated by Mizuho on Apr 26, 2016 to “Neutral”, Firm has raised the Price Target to $ 132 from a previous price target of $119 .Company shares were Reiterated by Canaccord Genuity on Apr 26, 2016 to “Buy”, Firm has raised the Price Target to $ 140 from a previous price target of $135 .Company shares were Reiterated by Barclays on Apr 26, 2016 to “Overweight”, Firm has raised the Price Target to $ 155 from a previous price target of $152 .

Laboratory Corporation of America Holdings is an independent clinical laboratory company in the United States. Through a national network of laboratories the Company offers a range of clinical laboratory tests that are used by the medical profession in core testing patient diagnosis and in the monitoring and treatment of disease. The Company manages its operations through two segments: the Clinical diagnostics laboratory segment which includes core testing as well as genomic and esoteric testing; and the Other segment which consists of the Company’s non-United States clinical diagnostic laboratory operations in Ontario Canada. It also provides specialty testing services in the areas of allergy clinical trials diagnostic genetics women’s health cardiovascular disease identity forensics infectious disease endocrinology oncology coagulation occupational testing and pain management.

Leave a Reply

Laboratory Corp. of America Holdings - Is it time to Sell?

Top Brokerage Firms are advising their investors on Laboratory Corp. of America Holdings. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.